tiprankstipranks
Agios Pharma (AGIO)
NASDAQ:AGIO
US Market

Agios Pharma (AGIO) Income Statement

Compare
620 Followers

Agios Pharma Income Statement

Last quarter (Q4 2024), Agios Pharma's total revenue was $10.73M, an increase of 51.06% from the same quarter last year. In Q4, Agios Pharma's net income was $-96.52M. See Agios Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 36.50M$ 26.82M$ 14.24M$ 0.00$ 203.20M
Gross Profit
$ 32.33M$ 17.32M$ 12.54M$ -18.78M$ 200.39M
Operating Expenses
$ 458.07M$ 408.81M$ 401.58M$ 378.42M$ 516.54M
Depreciation and Amortization
$ 0.00$ 6.62M$ 18.56M$ 18.78M$ 18.77M
EBITDA
$ -425.74M$ -384.86M$ -380.48M$ -337.73M$ -326.13M
Operating Income
$ -425.74M$ -391.49M$ -389.05M$ -378.42M$ -316.15M
Other Income/Expenses
$ 1.14B$ 39.40M$ 157.25M$ 21.91M$ 6.61M
Pretax Income
$ 717.97M$ -352.09M$ -231.80M$ -356.51M$ -327.37M
Net Income
$ 673.73M$ -352.09M$ -74.56M$ 1.60B$ -335.22M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 11.86$ -6.33$ -1.36$ 26.55$ -4.86
Diluted EPS
$ 11.64$ -6.33$ -1.36$ 26.55$ -4.86
Weighted Average Shares Outstanding
56.81M 55.65M 54.79M 60.45M 69.00M
Weighted Average Shares Outstanding (Diluted)
57.89M 55.65M 54.79M 60.45M 69.00M
Currency in USD

Agios Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis